Tuesday, April 17, 2018 12:26:54 PM
https://www.fda.gov/advisorycommittees/calendar/ucm597971.htm
https://www.marketwatch.com/story/gw-pharma-shares-surge-on-fda-briefing-document-that-hints-at-approval-of-cannabis-derived-drug-2018-04-17
Recent UBQU News
- Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • InvestorsHub NewsWire • 06/11/2024 02:13:55 PM
- Ubiquitech Software Corporation Retains Vitello Capital Ltd. to Aid Strategic Planning and Assess Global Acquisition Opportunities • InvestorsHub NewsWire • 10/11/2023 12:09:01 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM